In 2023, Business Enterprise R&D Expenditure in Human Health Activities in Germany stood at $10.04 million. Forecasts indicate a steady increase, reaching $18.16 million in 2028. Year-on-year growth rates from 2024 to 2028 are estimated to be approximately 15% per annum. The five-year CAGR is projected to be around 13%, reflecting strong investment growth driven by technological advances and healthcare demands.
Future trends to watch for include:
- The impact of emerging biotech industries on R&D expenditure.
- Government policy changes influencing healthcare spending.
- The role of digital health innovations, such as AI, on investment strategies.
